SAN FRANCISCO, April 11, 2017 /PRNewswire/ --
The global immunohistochemistry (IHC) market isestimated to reach a value of USD 3.1 billion by 2025, according to a new report by Grand View Research, Inc. The rising prevalence of cancer and increasing healthcare expenses driven by expanding aging population base are
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
Cancer has high morbidity and mortality risk associated with them. The diagnosis of the disease is majorly dependent on the stage of the disease at admission. This has led to the high demand of immunohistochemistry products. IHC staining process is performed on cancer tissues to reveal the presence of HER2 receptors and/or hormone receptors on their surface. This information plays a vital role in planning the treatment for the disease, creating a demand for immunohistochemistry products. In addition, the rising popularity of targeted immunotherapy and biologic therapy for anticancer drug development and the increasing approvals of the same by the FDA to treat specific types of cancer are expected to benefit the growth in the long run.
Other important factors driving growth include the alarming rise in healthcare spending and the shift in focus on value-based healthcare solutions. In 2015, the U.S. healthcare spending witnessed an increase of 5.8% to reach a value of USD 3.2 trillion. To curb the issue and establish a more value-based healthcare delivery, hospitals and care facilities are adopting a more specific and targeted therapy for better outcomes.
Browse full research report with TOC on "Immunohistochemistry (IHC) Market Analysis By Product (Antibodies, Reagents, Equipment, Kits), By Application (Diagnostics, Drug Testing), By End-Use (Hospitals, Diagnostic Laboratories, Research Institutes), And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/immunohistochemistry-ihc-market
Further key findings from the report suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the immunohistochemistry market on the basis of product, application, and end-use:
Read Our Blog: Rising incidence of cancer is expected to lead the immunohistochemistry market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!